{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/relugolix",
  "country": "GB",
  "medicine": "Relugolix",
  "activeIngredient": "relugolix",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Orgovyx 120 mg Film-Coated Tablets",
    "licenceNumber": "PLPI457631848",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/9648957f3bf94065e02199911f3593f90786dc06",
    "leafletDate": "2025-08-22"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 25,
    "wordingFoundInLeaflet": 25,
    "notFound": 0
  },
  "reviewedBy": null,
  "whatItIsFor": "Orgovyx is a tablet used to treat adults with advanced prostate cancer that responds to hormone therapy. It is also used before or together with radiotherapy for high-risk localised and locally advanced prostate cancer.",
  "keyFacts": [
    "Orgovyx works by lowering testosterone to very low levels, which stops prostate cancer cells growing and dividing.",
    "Tell your doctor right away if you get dizziness, fainting, a pounding or racing heart or chest pain, as these can be signs of serious heart rhythm problems.",
    "Seek urgent medical attention for rapid swelling of the face, mouth, lips, tongue, throat, abdomen, arms or legs.",
    "Many medicines can interfere with Orgovyx or affect heart rhythm, so tell your doctor about everything you take, including herbal remedies.",
    "Do not stop taking it without talking to your doctor first."
  ],
  "doNotTake": [
    "if you are allergic to relugolix or any of the other ingredients in this medicine"
  ],
  "checkWithDoctorFirst": [
    "Heart circulation conditions such as heart rhythm problems (arrhythmia); your doctor may check your body salts and the electrical activity of your heart",
    "Tell your doctor right away if you get dizziness, fainting, a pounding or racing heart (palpitations) or chest pain",
    "Liver disease; liver function may need to be monitored and use in severe liver disease has not been investigated",
    "Renal (kidney) disease",
    "Osteoporosis or any condition that affects the strength of your bones, as reduced testosterone may thin the bones",
    "Monitoring of your disease with a blood test for prostate-specific antigen (PSA)",
    "Not for use in children and adolescents under 18 years of age"
  ],
  "seriousSideEffects": [
    "Rapid swelling of your face, mouth, lips, tongue, throat, abdomen, or arms and legs (angioedema) (uncommon)"
  ],
  "sideEffectsByFrequency": [
    {
      "frequency": "Very common",
      "meaning": "More than 1 in 10 people",
      "effects": [
        "hot flush",
        "diarrhoea",
        "constipation",
        "muscle and joint pain",
        "tiredness"
      ]
    },
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "low red cell count (anaemia)",
        "breast enlargement in men (gynaecomastia)",
        "sleeplessness",
        "depression",
        "dizziness",
        "headache",
        "high blood pressure",
        "upset stomach including feeling sick (nausea)",
        "increased sweating",
        "rash",
        "decreased interest in sex",
        "increased weight",
        "increased blood sugar levels",
        "increased blood fat (triglyceride) levels",
        "increased blood cholesterol level"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "thinning of the bones (osteoporosis)",
        "increased liver enzymes",
        "hives (urticaria)"
      ]
    },
    {
      "frequency": "Rare",
      "meaning": "Up to 1 in 1,000 people",
      "effects": [
        "heart attack"
      ]
    },
    {
      "frequency": "Not known",
      "meaning": "The leaflet says how often is not known",
      "effects": [
        "changes in the electrocardiogram (QT prolongation)"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "Any other medicines, including medicines obtained without a prescription",
    "Medicines for heart rhythm problems (e.g. quinidine, procainamide, amiodarone, sotalol)",
    "Medicines that might increase the risk of heart rhythm problems (e.g. methadone, moxifloxacin, antipsychotics)",
    "Medicines for epilepsy (e.g. carbamazepine, phenytoin, phenobarbital)",
    "Medicines for bacterial infections (e.g. rifampicin, azithromycin, erythromycin, clarithromycin, gentamicin, tetracycline)",
    "Medicines for fungal infections (e.g. ketoconazole, itraconazole)",
    "Medicines for prostate cancer (e.g. apalutamide)",
    "Herbal remedies containing St John's Wort (Hypericum perforatum)",
    "Medicines for high blood pressure (e.g. carvedilol, verapamil)",
    "Medicines for arrhythmias (e.g. amiodarone, dronedarone, propafenone, quinidine)",
    "Medicines for angina (e.g. ranolazine)",
    "Immunosuppressants (e.g. cyclosporine)",
    "Medicines for HIV infections (e.g. ritonavir or ritonavir-containing combinations, efavirenz)",
    "Medicines for hepatitis C (e.g. telaprevir)"
  ],
  "pregnancyAndBreastfeeding": "Orgovyx is for men with prostate cancer and may possibly affect male fertility. It is not used in women who are or may be pregnant or breast-feeding; men having sex with a woman who can become pregnant should use a condom plus another effective birth control method during treatment and for 2 weeks after, and use a condom with a pregnant woman to protect the unborn child.",
  "howToTake": [
    "Take three tablets on the first day of treatment, then one tablet once a day, around the same time each day.",
    "Swallow the tablets whole with some liquid, with or without food.",
    "If you miss a dose by less than 12 hours, take it as soon as you remember; if more than 12 hours, skip it and take the next dose the following day as usual.",
    "Your doctor may change your dose if needed, and you should talk to your doctor before stopping."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}